NCT05514717
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05514717
Title A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mersana Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of South California RECRUITING Los Angeles California 90033 United States Details
University of California Los Angeles RECRUITING Los Angeles California 90095 United States Details
Stanford University Medical Center RECRUITING Stanford California 94305 United States Details
AdventHealth Celebration RECRUITING Celebration Florida 34747 United States Details
Emory Healthcare, Emory Clinic RECRUITING Atlanta Georgia 30322 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Karmanos Cancer Institute RECRUITING Detroit Michigan 48201 United States Details
Hackensack University Medical Center RECRUITING Hackensack New Jersey 07601 United States Details
New York University Medical Oncology Associates RECRUITING New York New York 10016 United States Details
Icahn School of Medicine at Mount Sinai RECRUITING New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
The Ohio State University Comprehensive Cancer Center RECRUITING Columbus Ohio 43212 United States Details
Tennessee Oncology, PLLC RECRUITING Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field